Status:
COMPLETED
Intravenous Versus Peribulbar Dexmedetomidine for Strabismus Surgery in Adults
Lead Sponsor:
Aswan University Hospital
Conditions:
Squint
Eligibility:
All Genders
20-60 years
Phase:
NA
Brief Summary
Using various adjuvants has become a trend in regional anesthesia practice to improve the quality of anesthesia and prolong postoperative analgesia. Dexmedetomidine, an alpha-2 agonist has been propos...
Detailed Description
Strabismus (misalignment of the eye) results from a difference in extraocular muscle function. Consequently, two different images, one from each eye, are transmitted to the brain, resulting in a loss ...
Eligibility Criteria
Inclusion
- The patient planned to perform a unilateral strabismus surgery
- Age: 20-60 years
- American Society of Anesthesiologists class I and II
Exclusion
- patients under the age of 20
- uncooperative patients
- Patients with coagulopathy
- patients who disincline to participate in the study will be excluded from the study
Key Trial Info
Start Date :
January 28 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 15 2023
Estimated Enrollment :
46 Patients enrolled
Trial Details
Trial ID
NCT05215158
Start Date
January 28 2022
End Date
September 15 2023
Last Update
November 15 2023
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Aswan University Hospital
Aswān, Egypt, 81511
2
Huda Fahmy
Aswān, Egypt, 81511